Scinai Immunotherapeutics Ltd Adr (SCNI)

Dec 16, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart

Dec 16, 2024

Dec 02, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board - Barchart

Dec 02, 2024

Nov 25, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results - Barchart

Nov 25, 2024

Oct 31, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 - Barchart

Oct 31, 2024

Aug 29, 2024

Scinai Regains Full Compliance with Nasdaq Listing Requirements - Benzinga

Aug 29, 2024

Aug 21, 2024

Scinai secures $2 million investment commitment By Investing.com - Investing.com India

Aug 21, 2024

Jul 17, 2024

Today's Market - InvestorPlace

Jul 17, 2024

Jul 17, 2024

Taking on analysts’ expectations and winning: Scinai Immunotherapeutics Ltd ADR (SCNI) - SETE News

Jul 17, 2024

Jul 15, 2024

Scinai reports promising psoriasis treatment study - Investing.com

Jul 15, 2024

Jul 15, 2024

Heather Campe, Sr. VP at Fuller H B Co, sells shares worth over $1.9m By Investing.com - Investing.com

Jul 15, 2024

Jul 15, 2024

Scinai Immunotherapeutics Ltd ADR Inc. (SCNI) Price Performance: The Role of Supply and Demand - The InvestChronicle

Jul 15, 2024

Jul 15, 2024

Scinai reports promising psoriasis treatment study By Investing.com - Investing.com

Jul 15, 2024

Jul 03, 2024

Baird lowers Lululemon shares target on mixed U.S. traffic and spending By Investing.com - Investing.com India

Jul 03, 2024

Jul 03, 2024

Scinai Immunotherapeutics gets Nasdaq compliance extension By Investing.com - Investing.com

Jul 03, 2024

Jul 02, 2024

ZUU Co. Ltd. executives purchase Pono Capital two shares worth $390 By Investing.com - Investing.com

Jul 02, 2024

Jul 02, 2024

Scinai Immunotherapeutics Ltd ADR (SCNI-Q) QuotePress Release - The Globe and Mail

Jul 02, 2024

Jul 02, 2024

Scinai reports Q1 results, progresses in pipeline By Investing.com - Investing.com South Africa

Jul 02, 2024

Jun 28, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) to Present at Europe Dermatology Drug Development Summit - The Globe and Mail

Jun 28, 2024

Jun 27, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Receive $900K Grant for CDMO Business Unit - The Globe and Mail

Jun 27, 2024

Jun 27, 2024

Sezzle Inc. ex-director sells over $33,000 in company stock By Investing.com - Investing.com

Jun 27, 2024

Jun 27, 2024

Ambit Capital sets Buy rating on Mahindra & Mahindra shares By Investing.com - Investing.com India

Jun 27, 2024

Jun 25, 2024

Sunrise New Energy unveils new battery anode material By Investing.com - Investing.com

Jun 25, 2024

Jun 25, 2024

Bank lifts XPeng stock rating to neutral By Investing.com - Investing.com

Jun 25, 2024

Jun 24, 2024

BridgeBio shares set for quick recovery post HELIOS-B results - Investing.com

Jun 24, 2024

Jun 21, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Showcasing Services at Upcoming BIO-Europe Spring 2024 - The Globe and Mail

Jun 21, 2024

Jun 21, 2024

Nvidia CFO Colette Kress sells shares worth over $12 million By Investing.com - Investing.com

Jun 21, 2024

Jun 20, 2024

BeiGene COO Wu Xiaobin sells over $500k in company stock - Investing.com

Jun 20, 2024

Jun 19, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Participation at BIO-Europe Munich 2023 - The Globe and Mail

Jun 19, 2024

Jun 18, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Releases Status Report on NASDAQ Compliance - The Globe and Mail

Jun 18, 2024

Jun 18, 2024

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Investing.com UK

Jun 18, 2024

Jun 17, 2024

Should investors be concerned about SCNI’s high price-to-sales ratio? - US Post News

Jun 17, 2024

Jun 17, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) to Showcase CDMO Services at Premier CPHI Barcelona Event - The Globe and Mail

Jun 17, 2024

Jun 17, 2024

Scinai Immunotherapeutics Ltd ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Jun 17, 2024

Jun 13, 2024

Scinai receives EIB terms for loan-to-equity conversion By Investing.com - Investing.com

Jun 13, 2024

Jun 10, 2024

Atlassian co-CEO Cannon-Brookes sells over $1.29 million in company stock By Investing.com - Investing.com

Jun 10, 2024

Jun 07, 2024

Scinai regains Nasdaq compliance, eyes EIB loan conversion By Investing.com - Investing.com

Jun 07, 2024

Jun 05, 2024

Doris Matsui invests over $1 million in Intrinsic Exchange Group By Investing.com - Investing.com

Jun 05, 2024

Jun 03, 2024

Dream Finders Homes CEO sells over $960k in company stock By Investing.com - Investing.com

Jun 03, 2024

May 29, 2024

UBS cuts Cielo SA stock target, downgrades to neutral By Investing.com - Investing.com

May 29, 2024

May 23, 2024

Paramount and Charter extend distribution deal By Investing.com - Investing.com

May 23, 2024

May 07, 2024

Scinai Immunotherapeutics Battles Nasdaq Delisting - TipRanks

May 07, 2024

May 06, 2024

Scinai Immunotherapeutics enacts reverse split to meet Nasdaq rules - Investing.com

May 06, 2024

Apr 09, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI), Scinai Bioservices Enter MSA with Ayana Pharma - The Globe and Mail

Apr 09, 2024

Apr 08, 2024

Biotech Rips Following Five-Year Master Service Agreement Release - The Globe and Mail

Apr 08, 2024

Jan 02, 2024

Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Agreement for Exercise of Outstanding Warrants - The Globe and Mail

Jan 02, 2024

Nov 01, 2023

Scinai Immunotherapeutics (NASDAQ: SCNI) Releases Q3 2023 Financial Report - The Globe and Mail

Nov 01, 2023

Jul 17, 2023

MARKET DATA - The Wall Street Journal

Jul 17, 2023

Jul 13, 2023

Hormel Foods Appoints Natosha Walsh VP of Marketing for Convenient Meals and Proteins - Investing.com India

Jul 13, 2023

Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011